(Q43580853)

24 November 2017

A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies (English)

1 reference

24 November 2017

1 reference

Iseki E

1

1 reference

24 November 2017

Kato M

2

1 reference

24 November 2017

Marui W

3

1 reference

24 November 2017

Uéda K

4

1 reference

24 November 2017

Kosaka K

5

1 reference

24 November 2017

1 April 2001

1 reference

Journal of the Neurological Sciences

24 November 2017

1 reference

24 November 2017

185

1 reference

24 November 2017

2

1 reference

24 November 2017

129-134

1 reference

Diffuse Lewy body disease: clinical features in 15 cases

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Diffuse Lewy body disease in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Visual responses of neurons in the dorsolateral amygdala of the alert monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Close relationship between spongiform change and ubiquitin-positive granular structures in diffuse Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Hippocampal pathology in diffuse Lewy body disease using ubiquitin immunohistochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

Levodopa-induced psychosis: a kindling phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900481-6

10.1016/S0022-510X(01)00481-6

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference